Bioactivity:

Eribulin �inhibits the proliferation of cancer cells by binding microtubule proteins and microtubules.�Eribulin is a microtubule targeting agent that is used in the treatment of metastatic breast cancer.

CAS nr:

253128-41-5

Purity:

98%

Molecular Weight:

729,9

SMILES:

C=C1C[C@@](CC[C@@]2(C[C@@]3([H])O4)O[C@]([C@](O[C@](C5)([H])CC6)([H])[C@@]6([H])O7)([H])[C@@]4([H])[C@]7([H])[C@@]3([H])O2)([H])O[C@@]1([H])CC[C@](C[C@@H](C)C8=C)([H])O[C@]8([H])C[C@@](O[C@H](C[C@H](O)CN)[C@@H]9OC)([H])[C@]9([H])CC5=O

Formula:

C40H59NO11

Pathway:

Others

Target:

Others